# Quoin Pharmaceuticals Ltd.: Form 8-K, filed Apr 30, 2025

- Company: [Quoin Pharmaceuticals Ltd.](/companies/qnrx.md) (CIK 1671502)
- Form: 8-K
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 17:09 ET
- Period: 2025-04-29
- Accession: 0001104659-25-042661
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671502/000110465925042661/tm2513688d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671502/000110465925042661/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671502/000110465925042661/tm2513688d1_8k.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-042661. Last ingested by Listed: Nov 13, 2026, 16:37 ET. No prices; not investment advice.
